News about Advertising and Marketing, including commentary and archival articles published in The New York Times.

Outlook Therapeutics' Lytenava is the first ophthalmic formulation of bevacizumab to be cleared for use by NICE for use in the NHS for wet AMD.

Return on investment (ROI) is a performance measure used to evaluate the efficiency of an investment or compare the efficiency of several investments.